M.D. David Owens - 16 Sep 2022 Form 4 Insider Report for Nexalin Technology, Inc. (NXL)

Role: Chief Medical Officer, Director
Signature: /s/ David Owens Name: David Owens, M.D.
Issuer symbol: NXL
Transactions as of: 16 Sep 2022
Net transactions value: +$10,375
Form type: 4
Filing time: 20 Sep 2022, 14:05:43 UTC
Previous filing: 19 Sep 2022
Next filing: 12 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NXL	Common Stock	Purchase	$10,375	+2,500	+1.8%	$4.15^*	141,174	16 Sep 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

M.D. David Owens is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Includes shares owed by LTB Investment Holdings LLC. Reporting Person has voting and dispositive control of the shares owned by LTB Investment Holdings LLC. Reporting Person has executed this Form 4 on behalf of himself and LTB Investment Holdings LLC